BRAF and spindle cell neoplasm: Interestingly, Ross et al. reported a case of malignant spindle cell tumor of the chest wall with a BRAF fusion that responded to treatment with an oral multikinase inhibitor sorafenib in combination with bevacizumab and temsirolimus [67].